SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-041459
Filing Date
2023-02-17
Accepted
2023-02-17 06:07:36
Documents
15
Period of Report
2023-02-16
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d440404d8k.htm   iXBRL 8-K 40692
2 EX-99.1 d440404dex991.htm EX-99.1 18301
7 GRAPHIC g440404g0217033646916.jpg GRAPHIC 4989
  Complete submission text file 0001193125-23-041459.txt   235162

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA amam-20230216.xsd EX-101.SCH 3871
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE amam-20230216_def.xml EX-101.DEF 13637
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE amam-20230216_lab.xml EX-101.LAB 22566
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE amam-20230216_pre.xml EX-101.PRE 14605
9 EXTRACTED XBRL INSTANCE DOCUMENT d440404d8k_htm.xml XML 5330
Mailing Address 10975 NORTH TORREY PINES ROAD LA JOLLA CA 92037
Business Address 10975 NORTH TORREY PINES ROAD LA JOLLA CA 92037 (858) 729-3339
Ambrx Biopharma Inc. (Filer) CIK: 0001836056 (see all company filings)

IRS No.: 571147346 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40505 | Film No.: 23640198
SIC: 2836 Biological Products, (No Diagnostic Substances)